Annual report pursuant to section 13 and 15(d)

Consolidated Statements of Cash Flows

v2.4.0.6
Consolidated Statements of Cash Flows (USD $)
In Thousands, unless otherwise specified
 12 Months Ended
Dec. 31, 2012
Dec. 31, 2011
OPERATING ACTIVITIES    
Net loss $ (1,489) $ (45,443)
Adjustments to reconcile net loss to net cash provided by operating activities:    
Gain on derivative liabilities   (83)
Loss on extinguishment of long-term debt 671  
Provision for doubtful accounts 5,251 4,099
Depreciation 5,668 6,386
Loss on disposal of medical equipment 237 1,731
Gain on sale of medical equipment (1,964) (2,753)
Amortization of intangible assets 2,734 2,662
Asset impairment charges   67,592
Amortization of deferred debt issuance costs 228 238
Stock-based compensation 964 1,185
Deferred income taxes (906) (23,423)
Changes in Assets - (Increase)/Decrease, exclusive of effects of acquisitions:    
Accounts receivable (6,490) (4,419)
Inventory (30) 33
Other current assets 249 (184)
Other assets 664 657
Changes in Liabilities - Increase/(Decrease), exclusive of effects of acquisitions:    
Accounts payable and other liabilities (335) (1,532)
NET CASH PROVIDED BY OPERATING ACTIVITIES 5,452 6,746
INVESTING ACTIVITIES    
Purchases of medical equipment and property (6,542) (8,211)
Proceeds from sale of medical equipment and property 3,978 4,218
Acquisition of intangible assets   (625)
Other asset acquisitions 6 (509)
NET CASH USED IN INVESTING ACTIVITIES (2,558) (5,127)
FINANCING ACTIVITIES    
Principal payments on term loans and capital lease obligations (9,631) (5,953)
Payoff of bank loan and revolver (25,851)  
Cash proceeds from bank loans and revolving credit facility 37,101 2,334
Payments on revolving credit facility   (1,750)
Payments for debt issuance costs (2,842)  
Common stock repurchased to satisfy taxes on stock based compensation (144) (102)
Treasury shares repurchased   (363)
NET CASH USED IN FINANCING ACTIVITIES (1,367) (5,834)
Net change in cash and cash equivalents 1,527 (4,215)
Cash and cash equivalents, beginning of period 799 5,014
Cash and cash equivalents, end of period 2,326 799
SUPPLEMENTAL DISCLOSURES    
Cash paid for interest (including swap payments) 3,112 1,934
Cash paid for income taxes 79 249
NON-CASH TRANSACTIONS    
Additions to medical equipment and property (a) 121 [1] 1,008 [1]
Medical equipment acquired pursuant to a capital lease $ 522 $ 2,300
[1] Amounts consist of current liabilities for medical equipment that have not been included in investing activities. These amounts have not been paid for as of December 31, 2012, and 2011, but will be included as a cash outflow from investing activities for purchases of medical equipment and property when paid.